Skip to main content
Top
Published in: Abdominal Radiology 6/2015

01-08-2015

Histogram analysis for characterization of indeterminate adrenal nodules on noncontrast CT

Authors: Michael F. Lin, Lauren Q. Chang-Sen, Jay P. Heiken, Thomas K. Pilgram, Kyongtae T. Bae

Published in: Abdominal Radiology | Issue 6/2015

Login to get access

Abstract

Objective: To determine the effectiveness of the CT histogram method to characterize indeterminate adrenal nodules above 10 Hounsfield units (HU) on noncontrast CT. Materials and methods: Retrospective review of clinical CT data from January 2005 through 2008 identified 194 indeterminate adrenal nodules (>10 HU on noncontrast CT) in 175 patients. 20 nodules in 18 patients were excluded due to large standard deviation (SD > 30) of HU values. Of the remaining 174 nodules, 131 were classified as benign lipid-poor nodules based on size stability for ≥1 year (104), in- and opposed-phase MRI (17), adrenal washout CT (3), or biopsy (7). 43 were classified as malignant by size increase over a short time (30), avid FDG uptake on PET/CT (15), or biopsy (5). Histogram analysis was performed by drawing a circular region of interest on all adrenal nodules. Mean attenuation, total number of pixels, number of negative pixels, and percentage of negative pixels were recorded for each nodule. Results: At the threshold value of >10% negative pixels, 59/131 benign nodules were correctly characterized, but 1/43 malignant nodules was falsely characterized as benign (sensitivity 45%, specificity 98%, positive predictive value 98%). With a slightly higher threshold value of >15% negative pixels, there were no false benign judgments. 36 nodules had more than 15% negative pixels, all of which were benign (sensitivity 27%, specificity 100%, positive predictive value 100%). In the subgroup of benign nodules measuring 11–20 HU, 80% and 54% were identified with threshold values of >10% and >15% negative pixels, respectively. Conclusion: The CT histogram method with a threshold value of >10% negative pixels can identify many benign adrenal nodules with attenuation values >10 HU on unenhanced CT with extremely high specificity. A threshold of >15% negative pixels can achieve 100% specificity. This method is highly robust provided very “noisy” CT examinations (SD > 30) are eliminated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Song JH, Chaudhry FS, Mayo-Smith WW (2007) The incidental indeterminate adrenal mass on CT (>10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR 189:1119–1123PubMedCrossRef Song JH, Chaudhry FS, Mayo-Smith WW (2007) The incidental indeterminate adrenal mass on CT (>10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR 189:1119–1123PubMedCrossRef
2.
go back to reference Lam KY (1994) The pathology of adrenal tumours. Cancer J 7:181–187 Lam KY (1994) The pathology of adrenal tumours. Cancer J 7:181–187
3.
go back to reference Lee MJ, Hahn PF, Papanicolaou N, et al. (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415–418PubMedCrossRef Lee MJ, Hahn PF, Papanicolaou N, et al. (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415–418PubMedCrossRef
4.
go back to reference Korobkin M, Brodeur FJ, Yutzy GG, et al. (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 166:531–536PubMedCrossRef Korobkin M, Brodeur FJ, Yutzy GG, et al. (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 166:531–536PubMedCrossRef
5.
go back to reference Boland G, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 171:201–204PubMedCrossRef Boland G, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 171:201–204PubMedCrossRef
6.
go back to reference Pena CS, Boland GL, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802PubMedCrossRef Pena CS, Boland GL, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802PubMedCrossRef
7.
go back to reference Blake MA, Kalra MK, Sweeney AT, et al. (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585PubMedCrossRef Blake MA, Kalra MK, Sweeney AT, et al. (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585PubMedCrossRef
8.
go back to reference Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR (2006) CT histogram analysis in pathologically proven adrenal masses. AJR 187:191–196PubMedCrossRef Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR (2006) CT histogram analysis in pathologically proven adrenal masses. AJR 187:191–196PubMedCrossRef
9.
go back to reference Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP (2003) Adrenal masses: CT characterization with histogram analysis method. Radiology 228:735–742PubMedCrossRef Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP (2003) Adrenal masses: CT characterization with histogram analysis method. Radiology 228:735–742PubMedCrossRef
10.
go back to reference Ho LM, Paulson EK, Brady MJ, Wong TZ, Schindera ST (2008) Lipid-poor adenoma on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR 191:234–238PubMedCrossRef Ho LM, Paulson EK, Brady MJ, Wong TZ, Schindera ST (2008) Lipid-poor adenoma on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR 191:234–238PubMedCrossRef
11.
go back to reference Jhaveri KS, Wong F, Ghai S, Haider MA (2006) Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR 187:1303–1308PubMedCrossRef Jhaveri KS, Wong F, Ghai S, Haider MA (2006) Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR 187:1303–1308PubMedCrossRef
12.
go back to reference Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR 192:956–962PubMedCrossRef Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR 192:956–962PubMedCrossRef
13.
go back to reference Lopez-Beltran A, Amin MB, Oliveira PS, et al. (2010) Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Am J Surg Pathol 34:371–376PubMedCrossRef Lopez-Beltran A, Amin MB, Oliveira PS, et al. (2010) Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Am J Surg Pathol 34:371–376PubMedCrossRef
14.
go back to reference Sydow BD, Rosen MA, Siegelman ES (2006) Intracellular lipid within metastatic hepatocellular carcinoma of the adrenal gland: a potential diagnostic pitfall of chemical shift imaging of the adrenal gland. AJR 187:W550–W551PubMedCrossRef Sydow BD, Rosen MA, Siegelman ES (2006) Intracellular lipid within metastatic hepatocellular carcinoma of the adrenal gland: a potential diagnostic pitfall of chemical shift imaging of the adrenal gland. AJR 187:W550–W551PubMedCrossRef
15.
go back to reference Shinozaki K, Yoshimitsu K, Honda H, et al. (2001) Metastatic adrenal tumor from clear-cell renal cell carcinoma: a pitfall of chemical shift MR imaging. Abdom Imaging 26:439–442PubMedCrossRef Shinozaki K, Yoshimitsu K, Honda H, et al. (2001) Metastatic adrenal tumor from clear-cell renal cell carcinoma: a pitfall of chemical shift MR imaging. Abdom Imaging 26:439–442PubMedCrossRef
16.
go back to reference Schwartz LH, Macari M, Huvos AG, Panicek DM (1996) Collision tumors of the adrenal gland: demonstration and characterization at MR imaging. Radiology 201:757–760PubMedCrossRef Schwartz LH, Macari M, Huvos AG, Panicek DM (1996) Collision tumors of the adrenal gland: demonstration and characterization at MR imaging. Radiology 201:757–760PubMedCrossRef
17.
go back to reference Chong S, Lee KS, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 26:1811–1826PubMedCrossRef Chong S, Lee KS, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 26:1811–1826PubMedCrossRef
18.
go back to reference Blake MA, Krishnamoorthy SK, Boland GW, et al. (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR 181:1663–1668PubMedCrossRef Blake MA, Krishnamoorthy SK, Boland GW, et al. (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR 181:1663–1668PubMedCrossRef
19.
go back to reference Tongdee R, Tongdee T, Goo JM, Bae KT (2004) Comparison of CT histogram analysis and mean attenuation methods in characterization of adrenal masses: a phantom study. (abstr) In: Radiological society of North America scientific assembly and annual meeting program. Oak Brook, IL: Radiological Society of North America Tongdee R, Tongdee T, Goo JM, Bae KT (2004) Comparison of CT histogram analysis and mean attenuation methods in characterization of adrenal masses: a phantom study. (abstr) In: Radiological society of North America scientific assembly and annual meeting program. Oak Brook, IL: Radiological Society of North America
20.
go back to reference Solomon JB, Christianson O, Samei E (2012) Quantitative comparison of noise texture across CT scanners from different manufacturers. Med Phys 39(10):6048–6055PubMedCrossRef Solomon JB, Christianson O, Samei E (2012) Quantitative comparison of noise texture across CT scanners from different manufacturers. Med Phys 39(10):6048–6055PubMedCrossRef
21.
go back to reference Sande EP, Martinsen AC, Hole EO, Olerud HM (2010) Interphantom and interscanner variations for Hounsfield units—establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 55(17):5123–5135PubMedCrossRef Sande EP, Martinsen AC, Hole EO, Olerud HM (2010) Interphantom and interscanner variations for Hounsfield units—establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 55(17):5123–5135PubMedCrossRef
Metadata
Title
Histogram analysis for characterization of indeterminate adrenal nodules on noncontrast CT
Authors
Michael F. Lin
Lauren Q. Chang-Sen
Jay P. Heiken
Thomas K. Pilgram
Kyongtae T. Bae
Publication date
01-08-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0307-6

Other articles of this Issue 6/2015

Abdominal Radiology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine